Hemispherx BioPharma Net Profit Margin 2006-2020 | AIM

Hemispherx BioPharma net profit margin from 2006 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Hemispherx BioPharma Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.00B $-0.01B inf%
2020-03-31 $0.00B $-0.01B inf%
2019-09-30 $0.00B $-0.01B inf%
2019-06-30 $0.00B $-0.01B inf%
2018-12-31 $0.00B $-0.01B inf%
2018-09-30 $0.00B $-0.01B inf%
2018-06-30 $0.00B $-0.01B inf%
2018-03-31 $0.00B $-0.01B inf%
2017-12-31 $0.00B $-0.01B inf%
2017-09-30 $0.00B $-0.01B inf%
2017-06-30 $0.00B $-0.01B inf%
2017-03-31 $0.00B $-0.01B inf%
2016-12-31 $0.00B $-0.01B inf%
2016-09-30 $0.00B $-0.01B inf%
2016-06-30 $0.00B $-0.01B inf%
2016-03-31 $0.00B $-0.01B inf%
2015-12-31 $0.00B $-0.02B inf%
2015-09-30 $0.00B $-0.02B inf%
2015-06-30 $0.00B $-0.02B inf%
2015-03-31 $0.00B $-0.02B inf%
2014-12-31 $0.00B $-0.02B inf%
2014-09-30 $0.00B $-0.02B inf%
2014-06-30 $0.00B $-0.02B inf%
2014-03-31 $0.00B $-0.02B inf%
2013-12-31 $0.00B $-0.02B inf%
2013-09-30 $0.00B $-0.02B inf%
2013-06-30 $0.00B $-0.02B inf%
2013-03-31 $0.00B $-0.02B inf%
2012-12-31 $0.00B $-0.02B inf%
2012-09-30 $0.00B $-0.02B inf%
2012-06-30 $0.00B $-0.01B inf%
2012-03-31 $0.00B $-0.01B inf%
2011-12-31 $0.00B $-0.01B inf%
2011-09-30 $0.00B $-0.01B inf%
2011-06-30 $0.00B $-0.01B inf%
2011-03-31 $0.00B $-0.01B inf%
2010-12-31 $0.00B $-0.01B inf%
2010-09-30 $0.00B $-0.01B inf%
2010-06-30 $0.00B $-0.01B inf%
2010-03-31 $0.00B $-0.01B inf%
2009-12-31 $0.00B $-0.01B inf%
2009-09-30 $0.00B $-0.01B inf%
2009-06-30 $0.00B $-0.01B inf%
2009-03-31 $0.00B $-0.01B inf%
2008-12-31 $0.00B $-0.01B inf%
2008-09-30 $0.00B $-0.01B inf%
2008-06-30 $0.00B $-0.02B inf%
2008-03-31 $0.00B $-0.02B inf%
2007-12-31 $0.00B $-0.02B inf%
2007-09-30 $0.00B $-0.02B inf%
2007-06-30 $0.00B $-0.02B inf%
2007-03-31 $0.00B $-0.02B inf%
2006-12-31 $0.00B $-0.02B inf%
2006-09-30 $0.00B $-0.02B inf%
2006-06-30 $0.00B $-0.02B inf%
2006-03-31 $0.00B $-0.02B inf%
2005-12-31 $0.00B $-0.01B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.080B $0.000B
AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases. The company's flagship products include Ampligen(R), Rintamod(R) and Alferon N Injection(R) which are in clinical stage. AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is based in Ocala, Florida.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.401B 42.89
Takeda Pharmaceutical (TAK) Japan $50.759B 8.85
Astellas Pharma (ALPMY) Japan $25.376B 0.00
Eisai (ESALY) Japan $23.672B 20.00
Merck (MKGAF) Germany $20.265B 26.58
UCB SA (UCBJF) Belgium $20.005B 0.00
Ono Pharmaceutical (OPHLF) Japan $15.938B 28.18
Catalent (CTLT) United States $14.630B 47.56
Grifols, S.A (GRFS) Spain $11.915B 14.56
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.683B 25.17
Neurocrine Biosciences (NBIX) United States $9.189B 35.57
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.221B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.076B 13.36
IPSEN SA ADR (IPSEY) France $7.818B 0.00
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Ionis Pharmaceuticals (IONS) United States $6.401B 40.55
Orion OYJ (ORINY) Finland $6.272B 21.76
Arrowhead Pharmaceuticals (ARWR) United States $6.078B 0.00
United Therapeutics (UTHR) United States $5.864B 12.49
Evotec AG (EVTCY) Germany $4.416B 142.16
Sage Therapeutics (SAGE) United States $3.734B 0.00
ChemoCentryx (CCXI) United States $3.599B 0.00
PTC Therapeutics (PTCT) United States $3.552B 0.00
FibroGen (FGEN) United States $3.466B 0.00
Hypermarcas (HYPMY) Brazil $3.163B 11.64
Nektar Therapeutics (NKTR) United States $2.846B 0.00
Pacira BioSciences (PCRX) United States $2.226B 58.51
Taro Pharmaceutical Industries (TARO) Israel $2.211B 11.28
Xencor (XNCR) United States $2.196B 0.00
Revolution Medicines (RVMD) United States $2.089B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.003B 0.00
Corcept Therapeutics (CORT) United States $1.980B 18.22
Cronos Group (CRON) Canada $1.914B 0.00
USANA Health Sciences (USNA) United States $1.693B 14.92
Ironwood Pharmaceuticals (IRWD) United States $1.520B 10.56
Heron Therapeutics (HRTX) United States $1.384B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.321B 12.60
Theravance Biopharma (TBPH) Cayman Islands $1.215B 0.00
Trillium Therapeutics (TRIL) Canada $1.188B 0.00
Endo (ENDP) Ireland $1.163B 1.72
Karyopharm Therapeutics (KPTI) United States $1.137B 0.00
Zogenix (ZGNX) United States $1.132B 0.00
Indivior (INVVY) United States $1.070B 13.27
CLINIGEN GP (CLIGF) United Kingdom $1.028B 0.00
Translate Bio (TBIO) United States $0.961B 0.00
ImmunoGen (IMGN) United States $0.944B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.883B 550.13
Esperion Therapeutics (ESPR) United States $0.848B 0.00
Vectura Group (VEGPF) United Kingdom $0.795B 0.00
Tilray (TLRY) Canada $0.719B 0.00
Ocular Therapeutix (OCUL) United States $0.663B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.647B 32.29
BioCryst Pharmaceuticals (BCRX) United States $0.641B 0.00
Radius Health (RDUS) United States $0.626B 0.00
Collegium Pharmaceutical (COLL) United States $0.621B 0.00
Flexion Therapeutics (FLXN) United States $0.588B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.562B 0.00
VAXART, INC (VXRT) United States $0.547B 0.00
Siga Technologies (SIGA) United States $0.501B 53.42
Spectrum Pharmaceuticals (SPPI) United States $0.493B 0.00
Aerie Pharmaceuticals (AERI) United States $0.479B 0.00
Molecular Templates (MTEM) United States $0.468B 0.00
Ardelyx (ARDX) United States $0.451B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.414B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.406B 0.00
Organogenesis Holdings (ORGO) United States $0.383B 0.00
Harpoon Therapeutics (HARP) United States $0.371B 0.00
Altimmune (ALT) United States $0.369B 0.00
TherapeuticsMD (TXMD) United States $0.359B 0.00
DURECT (DRRX) United States $0.357B 0.00
Profound Medical (PROF) Canada $0.336B 0.00
Akebia Therapeutics (AKBA) United States $0.335B 0.00
Concert Pharmaceuticals (CNCE) United States $0.327B 0.00
Redhill Biopharma (RDHL) Israel $0.318B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.313B 7.76
Avadel Pharmaceuticals (AVDL) Ireland $0.298B 0.00
MEI Pharma (MEIP) United States $0.296B 0.00
Innate Pharma SA (IPHYF) France $0.291B 0.00
Jounce Therapeutics (JNCE) United States $0.290B 13.71
KalVista Pharmaceuticals (KALV) United States $0.287B 0.00
Menlo Therapeutics (VYNE) United States $0.273B 0.00
Rafael Holdings (RFL) United States $0.264B 0.00
Lannett Co Inc (LCI) United States $0.257B 5.97
Calithera Biosciences (CALA) United States $0.252B 0.00
CASI Pharmaceuticals (CASI) United States $0.252B 0.00
CTI BioPharma (CTIC) United States $0.234B 0.00
Xeris Pharmaceuticals (XERS) United States $0.226B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.223B 0.00
IMV INC (IMV) Canada $0.214B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.211B 0.00
Aduro Biotech (KDNY) United States $0.211B 0.00
Nature's Sunshine Products (NATR) United States $0.205B 20.17
Nivalis Therapeutics (ALPN) United States $0.184B 0.00
Otonomy (OTIC) United States $0.183B 0.00
Heat Biologics (HTBX) United States $0.177B 0.00
Aquestive Therapeutics (AQST) United States $0.173B 0.00
Taiwan Liposome (TLC) Taiwan $0.172B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.172B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.164B 0.00
Aclaris Therapeutics (ACRS) United States $0.163B 0.00
OptiNose (OPTN) United States $0.163B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.161B 0.00
Champions Oncology (CSBR) United States $0.111B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.097B 0.00
MediWound (MDWD) Israel $0.093B 0.00
Lipocine (LPCN) United States $0.085B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.077B 0.00
ProPhase Labs (PRPH) United States $0.075B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.070B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.069B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.069B 0.00
ElectroCore (ECOR) United States $0.067B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.067B 0.00
Novan (NOVN) United States $0.066B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.065B 0.00
AgeX Therapeutics (AGE) United States $0.064B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.064B 0.00
Biomerica (BMRA) United States $0.063B 0.00
Infinity Pharmaceuticals (INFI) United States $0.062B 0.00
Addex Therapeutics (ADXN) Switzerland $0.060B 0.00
Nutriband (NTRB) United States $0.060B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.058B 0.00
Natural Alternatives (NAII) United States $0.051B 0.00
SCYNEXIS (SCYX) United States $0.047B 0.00
India Globalization Capital (IGC) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 26.82
Onconova Therapeutics (ONTX) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Recro Pharma (REPH) United States $0.042B 0.00
PolarityTE (PTE) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.034B 8.71
Bellicum Pharmaceuticals (BLCM) United States $0.032B 0.00
Neos Therapeutics (NEOS) United States $0.031B 0.00
GTx (ONCT) United States $0.030B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.028B 0.00
IsoRay (ISR) United States $0.027B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.027B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
Sundial Growers (SNDL) Canada $0.017B 0.00
Jaguar Animal Health (JAGX) United States $0.017B 0.00
Vical (BBI) United States $0.017B 0.00
Cyanotech (CYAN) United States $0.017B 25.09
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.014B 0.00
Flex Pharma (SLRX) United States $0.013B 0.00
Bio-Path Holdings (BPTH) United States $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Iterum Therapeutics (ITRM) Ireland $0.010B 0.00
Shineco (TYHT) China $0.008B 0.00
JanOne (JAN) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00